Enzo Biochem Stock Performance
| ENZ Stock | USD 1.08 0.05 4.85% |
Enzo Biochem has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.38, which means possible diversification benefits within a given portfolio. As returns on the market increase, Enzo Biochem's returns are expected to increase less than the market. However, during the bear market, the loss of holding Enzo Biochem is expected to be smaller as well. Enzo Biochem right now shows a risk of 1.84%. Please confirm Enzo Biochem sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if Enzo Biochem will be following its price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Enzo Biochem are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.3883 | Last Split Factor 105:100 | Forward Dividend Rate 0.4 | Dividend Date 2024-12-02 | Ex Dividend Date 2024-11-15 |
1 | Acquisition by Kara Cannon of 200000 shares of Enzo Biochem subject to Rule 16b-3 | 09/11/2024 |
2 | Enzo Biochem, Inc. Sees Significant Increase in Short Interest | 10/17/2024 |
3 | Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend | 10/29/2024 |
4 | Enzo Biochem, Inc. Declares 0.10 Dividend | 10/31/2024 |
5 | Will Enzo Biochem Spend Its Cash Wisely | 11/19/2024 |
6 | 100,000 Shares in Enzo Biochem, Inc. Bought by BBR Partners LLC | 11/29/2024 |
| Begin Period Cash Flow | 83.4 M |
Enzo |
Enzo Biochem Relative Risk vs. Return Landscape
If you would invest 103.00 in Enzo Biochem on September 1, 2024 and sell it today you would earn a total of 5.00 from holding Enzo Biochem or generate 4.85% return on investment over 90 days. Enzo Biochem is generating 0.0918% of daily returns assuming volatility of 1.8417% on return distribution over 90 days investment horizon. In other words, 16% of stocks are less volatile than Enzo, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Enzo Biochem Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enzo Biochem's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Enzo Biochem, and traders can use it to determine the average amount a Enzo Biochem's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0498
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ENZ | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.84 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Enzo Biochem is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enzo Biochem by adding it to a well-diversified portfolio.
Enzo Biochem Fundamentals Growth
Enzo Stock prices reflect investors' perceptions of the future prospects and financial health of Enzo Biochem, and Enzo Biochem fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enzo Stock performance.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0744 | ||||
| Profit Margin | (0.82) % | ||||
| Operating Margin | (0.39) % | ||||
| Current Valuation | 4.95 M | ||||
| Shares Outstanding | 52.24 M | ||||
| Price To Earning | 26.60 X | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 1.77 X | ||||
| Revenue | 31.91 M | ||||
| Gross Profit | 11.57 M | ||||
| EBITDA | (8.35 M) | ||||
| Net Income | (26.08 M) | ||||
| Cash And Equivalents | 82.37 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 3.51 M | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 2.21 X | ||||
| Book Value Per Share | 1.07 X | ||||
| Cash Flow From Operations | (26.26 M) | ||||
| Earnings Per Share | (0.19) X | ||||
| Market Capitalization | 56.42 M | ||||
| Total Asset | 85.76 M | ||||
| Retained Earnings | (294.43 M) | ||||
| Working Capital | 45.24 M | ||||
| Current Asset | 91.4 M | ||||
| Current Liabilities | 20.57 M | ||||
About Enzo Biochem Performance
Evaluating Enzo Biochem's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Enzo Biochem has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Enzo Biochem has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 144.35 | 85.69 | |
| Return On Tangible Assets | (0.30) | (0.29) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.30) | (0.29) | |
| Return On Equity | (0.46) | (0.49) |
Things to note about Enzo Biochem performance evaluation
Checking the ongoing alerts about Enzo Biochem for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enzo Biochem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Enzo Biochem has some characteristics of a very speculative penny stock | |
| The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 11.57 M. | |
| Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: 100,000 Shares in Enzo Biochem, Inc. Bought by BBR Partners LLC |
- Analyzing Enzo Biochem's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enzo Biochem's stock is overvalued or undervalued compared to its peers.
- Examining Enzo Biochem's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enzo Biochem's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enzo Biochem's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enzo Biochem's stock. These opinions can provide insight into Enzo Biochem's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.